Senior insider sale
Chief Business Officer at SUTRO BIOPHARMA, INC. — senior position signals high conviction
$156.3K
27.04K shares
What this filing means
SHTYLLA BRUNILDA plans to sell 27.04K shares of SUTRO BIOPHARMA, INC. valued at approximately $156.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/25/2023ACC: 0001972362-23-000707
Officer· Chief Business Officer
Since Mar 2023
27.04K
Shares to sell
$156.3K
Approx. market value
27.04K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months9
ESPP
COMPENSATION
3/15/2023
2.50KRESTRICTED STOCK
COMPENSATION
3/5/2023
2.59KRESTRICTED STOCK
COMPENSATION
3/4/2023
4KESPP
COMPENSATION
3/15/2022
1.25KRESTRICTED STOCK
COMPENSATION
3/5/2022
2.53KESPP
COMPENSATION
3/15/2021
2.27KRESTRICTED STOCK
COMPENSATION
9/26/2020
111.00RETAIL PURCHASE
CASH
5/12/2020
11.61KRESTRICTED STOCK
COMPENSATION
9/26/2019
175.00Total acquired27.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2023 | ESPP COMPENSATION | 2.50K | — |
3/5/2023 | RESTRICTED STOCK COMPENSATION | 2.59K | — |
3/4/2023 | RESTRICTED STOCK COMPENSATION | 4K | — |
3/15/2022 | ESPP COMPENSATION | 1.25K | — |
3/5/2022 | RESTRICTED STOCK COMPENSATION | 2.53K | — |
3/15/2021 | ESPP COMPENSATION | 2.27K | — |
9/26/2020 | RESTRICTED STOCK COMPENSATION | 111.00 | — |
5/12/2020 | RETAIL PURCHASE CASH | 11.61K | — |
9/26/2019 | RESTRICTED STOCK COMPENSATION | 175.00 | — |
| Total | 27.04K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
27.04K
Market value
$156.3K
8/25/2023
Total
Units
27.04K
Value
$156.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/25/2023 | 27.04K | $156.3K | NASDAQ | Planned |
| Total | 27.04K | $156.3K | ||